RxTrials president, Christine Pierre, has named Adam Chasse vice president of business development. Chasse, who has been head of prime sites for Quintiles, will begin immediately and be based in Triangle Park, N.C.

“I have collaborated with Adam for 16 years and have admired what he has accomplished personally and for his employer, but what really stands out for me is his integrity. Yes, he brings a global perspective and valuable experience gained by working for the largest contract research organization in the world, but, more importantly, he brings a vision for the future of our organization that is closely aligned with that of our other top managers,” said Pierre.

Chasse has served on the board of advisors for the Site Solutions Summit since its inception seven years ago. The Summit is an annual industry meeting organized by RxTrials Institute and focused on research sites’ best practices. RxTrials Institute is an RxTrials affiliate.

“I’m very, very excited because I’ve always admired RxTrials for its history of delivery and quality, and its forward-thinking approach to improving research practices,” said Chasse.

Chasse and Pierre agree that it is becoming increasingly difficult for independent research practices to leverage the economies of scale necessary to be successful. A network of research sites, they say, provides ways to keep sites busier and guarantee high-quality end results while assuring positive patient experiences.

RxTrials has eight research sites located in five states, all of which are located within clinical practices or hospitals.  “Adam will provide RxTrials with strategic site development and study placement opportunities focused on our clients’ needs,” said Pierre.